Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 12, 2023
Morbidity in Patients with Chronic Adrenal Insufficiency - Cardiovascular Risk Factors and Hospitalization Rate Compared to Population Based ControlsIrina Chifu, Marcus Quinkler, Barbara Altieri, et al.
Frontiers in Endocrinology|May 7, 2020
Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical CarcinomaRaimunde Liang, Isabel Weigand, Juliane Lippert, et al.
The Journal of Clinical Endocrinology and Metabolism|October 6, 2019
Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors < 2 CentimetersAntongiulio Faggiano, Roberta Modica, Fabio Lo Calzo, et al.
British Journal of Cancer|December 9, 2022
Efficacy and safety of radiation therapy in advanced adrenocortical carcinomaOtilia Kimpel, Paul Schindler, Laura Schmidt-Pennington, et al.
European Journal of Endocrinology|January 18, 2023
Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validationLeah T Braun, Frederick Vogel, German Rubinstein, et al.
Current Vascular Pharmacology|April 10, 2019
Calcium and Vitamin D Supplementation. Myths and Realities with Regard to Cardiovascular RiskGiovanna Muscogiuri, Luigi Barrea, Barbara Altieri, et al.
Oncotarget|December 29, 2016
Livin/BIRC7 expression as malignancy marker in adrenocortical tumorsBarbara Altieri, Silviu Sbiera, Silvia Della Casa, et al.
European Journal of Endocrinology|March 7, 2024
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinomaJuliane Lippert, Gabrielle Smith, Silke Appenzeller, et al.
Endocrine Connections|November 22, 2023
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinomaEmily Warmington, Gabrielle Smith, Vasileios Chortis, et al.
Pageof 12